Keywords: roche, sales, rise, swiss, pharmaceuticals, major, hoffmann-la
ROCHE 1992 SALES RISE BY 13%
Article | 18 January 1993
The Swiss pharmaceuticals major, Hoffmann-La Roche, has reported sales of 12.95 billion Swiss francs ($8.74 billion) for 1992, a rise of 13% in terms ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
